3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
3
Wilms Tumor
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioma
2
Ependymoma
2
Xanthogranuloma, Juvenile
1
Thyroid Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Pheochromocytoma
1
Melanoma
1
Histiocytic Sarcoma
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Central Nervous System Neoplasms
1
Interventions
AZD 6244
7
trametinib
4
mirdametinib
2
fludarabine
2
Inhalation
2
Acetylcysteine
2
thymoglobulin
1
talimogene laherparepvec
1
omipalisib
1
lorlatinib
1
fludarabine phosphate
1
encorafenib
1
dabrafenib
1
binimetinib
1
abemaciclib
1
Vincristine
1
Specimen Handling
1
Sirolimus
1
Rituximab
1
Radiation
1
N-monoacetylcystine
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Levetiracetam
1
Lasers, Solid-State
1
Lasers
1
Injections
1
Deoxycholic Acid
1
Cytarabine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neurofibromatosis 1
×
tipifarnib
×
90 days
×
Clear all
No trials found.